In our centre, T/ myeloid MPAL patients receive a more intensified induction regimen, FLAG‐Ida, while the treatment for ETP‐ALL is an ALL‐directed induction regimen. The gene discussed is IDUA; the disease is acute lymphoblastic leukemia.